메뉴 건너뛰기




Volumn 81, Issue 1, 2008, Pages 24-29

Reporting and analysis of open-label extension studies of anti-epileptic drugs

Author keywords

Anti epileptic drugs; Efficacy; ITT analysis; Open label extension

Indexed keywords

ETIRACETAM; GABAPENTIN; PLACEBO; TOPIRAMATE;

EID: 50649096800     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.04.007     Document Type: Article
Times cited : (16)

References (29)
  • 1
    • 28944454399 scopus 로고    scopus 로고
    • Long-term efficacy of levetiracetam for partial seizures
    • Abou-khalil B., and Schaich L. Long-term efficacy of levetiracetam for partial seizures. Seizure 14 (2005) 577-585
    • (2005) Seizure , vol.14 , pp. 577-585
    • Abou-khalil, B.1    Schaich, L.2
  • 2
    • 0028937118 scopus 로고
    • Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures
    • The International Gabapentin Study Group
    • Anhut H., Ashman P.J., Feuerstein T.J., Quebe-Fehling E., Saunders M., Baron B.A., and The International Gabapentin Study Group. Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures. J. Epilepsy 8 1 (1995) 44-50
    • (1995) J. Epilepsy , vol.8 , Issue.1 , pp. 44-50
    • Anhut, H.1    Ashman, P.J.2    Feuerstein, T.J.3    Quebe-Fehling, E.4    Saunders, M.5    Baron, B.A.6
  • 3
    • 0001196981 scopus 로고
    • Long-term follow-up of patients treated with topiramate for partial seizures
    • Ben-Menachem E. Long-term follow-up of patients treated with topiramate for partial seizures. Epilepsia 36 Suppl. 3 (1995) S152
    • (1995) Epilepsia , vol.36 , Issue.SUPPL. 3
    • Ben-Menachem, E.1
  • 5
    • 0034162331 scopus 로고    scopus 로고
    • A multi-centre, double-blind, randomised, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
    • Betts T., Waegemans T., and Crawford P. A multi-centre, double-blind, randomised, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9 (2000) 80-87
    • (2000) Seizure , vol.9 , pp. 80-87
    • Betts, T.1    Waegemans, T.2    Crawford, P.3
  • 6
    • 2042539816 scopus 로고    scopus 로고
    • Open-label study of UCB LO59 as add-on therapy in refractory partial epilepsy
    • Cameron N., Penovich P.E., Ritter F.J., and Espe-Lillo J. Open-label study of UCB LO59 as add-on therapy in refractory partial epilepsy. Epilepsia 37 Suppl. 5 (1996) 169
    • (1996) Epilepsia , vol.37 , Issue.SUPPL. 5 , pp. 169
    • Cameron, N.1    Penovich, P.E.2    Ritter, F.J.3    Espe-Lillo, J.4
  • 7
    • 0033854805 scopus 로고    scopus 로고
    • Levetiracetam for partial seizures: results of a double-blind randomised clinical trial
    • Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., and Leppik I. Levetiracetam for partial seizures: results of a double-blind randomised clinical trial. Neurology 55 (2000) 236-242
    • (2000) Neurology , vol.55 , pp. 236-242
    • Cereghino, J.J.1    Biton, V.2    Abou-Khalil, B.3    Dreifuss, F.4    Gauer, L.J.5    Leppik, I.6
  • 8
    • 84970861456 scopus 로고
    • Identifying relevant studies for systematic reviews
    • Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 309 (1994) 1286-1291
    • (1994) BMJ , vol.309 , pp. 1286-1291
    • Dickersin, K.1    Scherer, R.2    Lefebvre, C.3
  • 9
    • 4744338860 scopus 로고    scopus 로고
    • Breaching the contract: the ethics of non-publication of research studies
    • Dowd D. Breaching the contract: the ethics of non-publication of research studies. Arch. Pediatr. Adolesc. Med. 158 (2004) 1014-1015
    • (2004) Arch. Pediatr. Adolesc. Med. , vol.158 , pp. 1014-1015
    • Dowd, D.1
  • 10
    • 35548966748 scopus 로고    scopus 로고
    • Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
    • STROBE Initiative
    • Elm E.V., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., and STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 (2007) 806-808
    • (2007) BMJ , vol.335 , pp. 806-808
    • Elm, E.V.1    Altman, D.G.2    Egger, M.3    Pocock, S.J.4    Gøtzsche, P.C.5    Vandenbroucke, J.P.6
  • 12
    • 0011083923 scopus 로고
    • Long term therapy with topiramate in patients with partial seizures.
    • Fincham R., and Schottelius D. Long term therapy with topiramate in patients with partial seizures. Epilepsia 36 Suppl. 4 (1995) 56
    • (1995) Epilepsia , vol.36 , Issue.SUPPL. 4 , pp. 56
    • Fincham, R.1    Schottelius, D.2
  • 13
    • 0027988184 scopus 로고
    • Efficacy and tolerance of long-term, high-dose gabapentin: additional observations
    • Handforth A., and Treiman D.M. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia 35 5 (1994) 1032-1037
    • (1994) Epilepsia , vol.35 , Issue.5 , pp. 1032-1037
    • Handforth, A.1    Treiman, D.M.2
  • 15
    • 0030873963 scopus 로고    scopus 로고
    • New anti-epileptic drugs: a systematic review of their efficacy and tolerability
    • Marson A.G., Kadir Z.A., and Chadwick D.W. New anti-epileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38 8 (1997) 859-880
    • (1997) Epilepsia , vol.38 , Issue.8 , pp. 859-880
    • Marson, A.G.1    Kadir, Z.A.2    Chadwick, D.W.3
  • 16
    • 0011083925 scopus 로고    scopus 로고
    • Topiramate in the treatment of refractory partial epilepsy: a 2 year long-term follow-up
    • Michelucci R., Passarelli D., and Tassinari C.A. Topiramate in the treatment of refractory partial epilepsy: a 2 year long-term follow-up. Epilepsia 37 Suppl. 4 (1996) 70
    • (1996) Epilepsia , vol.37 , Issue.SUPPL. 4 , pp. 70
    • Michelucci, R.1    Passarelli, D.2    Tassinari, C.A.3
  • 17
    • 0011107199 scopus 로고
    • Topiramate as long-term treatment in refractory partial epilepsy
    • Mikkelsen M., Ostergaard L., and Dam M. Topiramate as long-term treatment in refractory partial epilepsy. Epilepsia 34 Suppl. 2 (1993) 123
    • (1993) Epilepsia , vol.34 , Issue.SUPPL. 2 , pp. 123
    • Mikkelsen, M.1    Ostergaard, L.2    Dam, M.3
  • 19
    • 0001196978 scopus 로고
    • Long-term efficacy and safety of topiramate
    • Privitera M. Long-term efficacy and safety of topiramate. Epilepsia 36 Suppl. 3 (1995) S152
    • (1995) Epilepsia , vol.36 , Issue.SUPPL. 3
    • Privitera, M.1
  • 20
    • 0029884747 scopus 로고    scopus 로고
    • Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
    • Privitera M., Fincham R., Penry J., Reife R., Kramer L., Pledger G., and Karim R. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 46 6 (1996) 1678-1683
    • (1996) Neurology , vol.46 , Issue.6 , pp. 1678-1683
    • Privitera, M.1    Fincham, R.2    Penry, J.3    Reife, R.4    Kramer, L.5    Pledger, G.6    Karim, R.7
  • 21
    • 24644450203 scopus 로고
    • Long term efficacy of gabapentin in the treatment of partial seizures
    • Schear M.J., Wiener J.A., and Rowan A.J. Long term efficacy of gabapentin in the treatment of partial seizures. Epilepsia 32 Suppl. 3 (1991) 6
    • (1991) Epilepsia , vol.32 , Issue.SUPPL. 3 , pp. 6
    • Schear, M.J.1    Wiener, J.A.2    Rowan, A.J.3
  • 22
    • 10244250992 scopus 로고
    • Adjuvant topiramate in intractable partial epilepsy
    • Sharief M.K., Sander J.W., Patsalos P.N., and Shorvon S.D. Adjuvant topiramate in intractable partial epilepsy. Epilepsia 34 Suppl. 6 (1993) 41
    • (1993) Epilepsia , vol.34 , Issue.SUPPL. 6 , pp. 41
    • Sharief, M.K.1    Sander, J.W.2    Patsalos, P.N.3    Shorvon, S.D.4
  • 23
    • 10544255353 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
    • Sharief M., Viteri C., Ben-Menachem E., Weber M., Reife R., Pledger G., and Karim R. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 25 (1996) 217-224
    • (1996) Epilepsy Res. , vol.25 , pp. 217-224
    • Sharief, M.1    Viteri, C.2    Ben-Menachem, E.3    Weber, M.4    Reife, R.5    Pledger, G.6    Karim, R.7
  • 24
    • 0026095572 scopus 로고
    • Double-blind study of gabapentin in the treatment of partial seizures
    • Sivenius J., Kalviainen R., Ylinen A., and Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 32 4 (1991) 539-542
    • (1991) Epilepsia , vol.32 , Issue.4 , pp. 539-542
    • Sivenius, J.1    Kalviainen, R.2    Ylinen, A.3    Riekkinen, P.4
  • 25
    • 0028145474 scopus 로고
    • Long-term study with gabapentin in patients with drug-resistant epileptic seizures
    • Sivenius J., Ylinen A., Kalviainen R., and Riekkinen Sr. P.J. Long-term study with gabapentin in patients with drug-resistant epileptic seizures. Arch. Neurol. 51 (1994) 1047-1050
    • (1994) Arch. Neurol. , vol.51 , pp. 1047-1050
    • Sivenius, J.1    Ylinen, A.2    Kalviainen, R.3    Riekkinen Sr., P.J.4
  • 27
    • 24644446896 scopus 로고    scopus 로고
    • Open label extension studies: research or marketing?
    • Taylor G.J., and Wainwright P. Open label extension studies: research or marketing?. Brit. Med. J. 331 7516 (2005) 572-574
    • (2005) Brit. Med. J. , vol.331 , Issue.7516 , pp. 572-574
    • Taylor, G.J.1    Wainwright, P.2
  • 28
    • 0027374164 scopus 로고
    • Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study
    • The US Gabapentin Study Group No 5
    • The US Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43 (1993) 2292-2298
    • (1993) Neurology , vol.43 , pp. 2292-2298
  • 29
    • 0028343267 scopus 로고
    • The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug resistant partial epilepsy
    • The US Gabapentin Study Group
    • The US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug resistant partial epilepsy. Epilepsy Res. 18 (1994) 67-73
    • (1994) Epilepsy Res. , vol.18 , pp. 67-73


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.